3-METHYLCHOLANTHRENE-MEDIATED INDUCTION OF CYTOCHROME P4501A2 IN HUMAN HEPATOMA HEPG2 CELLS AS QUANTIFIED BY THE REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION

被引:32
作者
CHUNG, IJ
BRESNICK, E
机构
[1] DARTMOUTH COLL,SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH 03755
[2] NORRIS COTTON CANC CTR,HANOVER,NH 03755
关键词
D O I
10.1006/abbi.1994.1413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The feasibility of using HepG2 human hepatoma cells to study the regulation of the expression of the cytochrome P4501A2 gene (CYP1A2) was examined. The reverse transcription-polymerase chain reaction (RT-PCR) assay revealed that HepG2 cells constitutively express CYP1A2 and are able to respond to 3-methylcholanthrene (3MC) by an induction of CYP1A2 mRNA. In these studies, selected sequences from intron-exon junctions were used as mRNA-specific primers for both CYP1A2 and the beta-actin gene. The level of induction was quantitated based on two parameters within the exponential phase of the amplification: the difference in the number of cycles that yields the same level of amplification and the efficiency of the PCR reaction. Using this method, it was estimated that the CYP1A2 steady-state mRNA level increased to a maximum of 12-fold at 24 h after exposure of the cells to 3MC. Both a reduction in basal expression as well as an increased accumulation of CYP1A2 mRNA appeared responsible for the overall induction at 24 and 48 h. These results suggested that the HepG2 cell line would be appropriate for studying the regulation of CYP1A2 expression. (C) 1994 Academic Press, Inc.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 38 条
  • [1] THE 4S BINDING-PROTEIN ACTS AS A TRANS-REGULATOR OF THE POLYCYCLIC HYDROCARBON-INDUCIBLE CYTOCHROME-P450
    BRESNICK, E
    SIEGEL, LI
    HOUSER, WH
    [J]. CANCER AND METASTASIS REVIEWS, 1988, 7 (01) : 51 - 65
  • [2] BRESNICK E, 1993, HDB EXPT PHARM, V105, P503
  • [3] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [4] CONNEY AH, 1967, PHARMACOL REV, V19, P317
  • [5] INTERLEUKIN-6 DOWN REGULATES THE EXPRESSION OF TRANSCRIPTS ENCODING CYTOCHROME P450 IA1, IA2 AND IIIA3 IN HUMAN HEPATOMA-CELLS
    FUKUDA, Y
    ISHIDA, N
    NOGUCHI, T
    KAPPAS, A
    SASSA, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) : 960 - 965
  • [6] Gelboin H V, 1967, Adv Cancer Res, V10, P1, DOI 10.1016/S0065-230X(08)60076-7
  • [7] CYTOCHROME-P-450 AND ITS ROLE IN DRUG-METABOLISM
    GILLETTE, JR
    SASAME, HA
    DAVIS, DC
    [J]. ANNUAL REVIEW OF PHARMACOLOGY, 1972, 12 : 57 - +
  • [8] GONZALEZ FJ, 1984, MOL PHARMACOL, V26, P117
  • [9] GUENTHNER TM, 1977, J BIOL CHEM, V252, P8981
  • [10] IONNIDES C, 1990, DRUG METAB REV, V22, P1